Napo Pharmaceuticals, a Jaguar Health Family Company, Submit

Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea

Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea

jamaicantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicantimes.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Yemen , Milan , Lombardia , Italy , Italian , Magdalena Biosciences , Napo Pharmaceuticals , Jaguar Health , Jaguar Health Inc , Drug Administration , Filament Health Corp , National Institutes Of Health , Us Department Of Health Human Services , National Institute Of Allergy , Jaguar Entheogen Therapeutics Initiative , Jaguar Animal Health , Centers For Disease , Jaguar Health Family Of Companies , Tropical Disease Priority Review Voucher , National Institute , Infectious Diseases , Vice President , Investigational New Drug , National Institutes , Disease Control , New Drug Application , Jaguar Health Family , Napo Therapeutics , Animal Health , Filament Health , Entheogen Therapeutics Initiative ,